FDA OKs Pfizer COVID-19 Vaccine For 12-15 Age Group

Content Curator
A doctor prepares to administer a vaccine injection at New York-Presbyterian Lawrence Hospital in Bronxville, N.Y., in January. The Food and Drug Administration has approved emergency use authorization of the Pfizer/BioNTech vaccine for patients ages 12 to 15.

Pfizer said in late March that clinical trials found "100% efficacy and robust antibody responses" to the coronavirus in 12- to 15-year-olds.

(Image credit: Kevin Hagen/AP)